INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia in adults (see Pharmacology: Pharmacodynamics: Clinical Studies: Schizophrenia under Actions).
Schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants (see Pharmacology: Pharmacodynamics: Clinical Studies: Schizoaffective Disorder under Actions).